uniQure N.V. (QURE) stock
QURENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30224% above fair value
$20.78−1.10 (-5.03%)
Close on Nov 17, 2026Market cap $1.44BP/E –Yield –
uniQure profit margin
Profit margin (net margin) is net income as a percentage of revenue.
uniQure's profit margin for the twelve months ending Jun 30, 2026 was -1350.7%. For fiscal 2025 it was -1236.0%, against -883.4% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -1236.0% | −352.6 |
| FY2024 | Dec 31, 2024 | -883.4% | +1063.7 |
| FY2023 | Dec 31, 2023 | -1947.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -1387.8% | −670.9 |
| Q1 FY2026 | Mar 31, 2026 | -1502.9% | +1281.8 |
| Q4 FY2025 | Dec 31, 2025 | -666.1% | +737.1 |
| Q3 FY2025 | Sep 30, 2025 | -2175.9% | −235.4 |
| Q2 FY2025 | Jun 30, 2025 | -716.8% | −210.8 |
| Q1 FY2025 | Mar 31, 2025 | -2784.7% | – |
| Q4 FY2024 | Dec 31, 2024 | -1403.2% | – |
| Q3 FY2024 | Sep 30, 2024 | -1940.4% | – |
| Q2 FY2024 | Jun 30, 2024 | -506.0% | – |
See a number that looks wrong?